1. Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapy. (November 2011) Authors: Waterhouse, Dawn N; Yapp, Donald; Verreault, Maite; Anantha, Malathi; Sutherland, Brent; Bally, Marcel B Journal: Nanomedicine Issue: Volume 6:Number 9(2011) Page Start: 1645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗